Home » Stocks » GHSI

Guardion Health Sciences, Inc. (GHSI)

Stock Price: $0.635 USD 0.010 (1.67%)
Updated Jan 15, 2021 4:00 PM EST - Market closed
After-hours: $0.629 -0.006 (-0.95%) Jan 15, 7:59 PM
Market Cap 58.17M
Revenue (ttm) 1.93M
Net Income (ttm) -9.25M
Shares Out 88.32M
EPS (ttm) -0.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 15
Last Price $0.635
Previous Close $0.625
Change ($) 0.010
Change (%) 1.67%
Day's Open 0.620
Day's Range 0.604 - 0.680
Day's Volume 28,065,995
52-Week Range 0.167 - 0.734

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
InvestorPlace - 1 week ago

Guardion Health Sciences (GHSI) is seeing a massive spike in its stock on Wednesday despite a lack of news concerning the company. The post GHSI Stock: 11 Things for Investors to Know About Gu...

GlobeNewsWire - 2 weeks ago

SAN DIEGO, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported...

GlobeNewsWire - 1 month ago

SAN DIEGO, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported...

GlobeNewsWire - 2 months ago

Guardion A lso Provides Corporate Update

GlobeNewsWire - 2 months ago

New Study Published on October 26, 2020 in Peer-Reviewed Journal “Nutrients” New Study Published on October 26, 2020 in Peer-Reviewed Journal “Nutrients”

GlobeNewsWire - 2 months ago

SAN DIEGO, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) is providing the following answers to frequently asked questions to its...

GlobeNewsWire - 2 months ago

SAN DIEGO, Oct. 26, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported...

GlobeNewsWire - 3 months ago

SAN DIEGO, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) is providing an update to shareholders with regard to its business plan...

GlobeNewsWire - 4 months ago

Annual stockholder meeting scheduled for Thursday, October 29, 2020

GlobeNewsWire - 4 months ago

Ho Wah Genting Berhad Receives Product Registration Approval For Astramern Nutra V Ho Wah Genting Berhad Receives Product Registration Approval For Astramern Nutra V

Seeking Alpha - 5 months ago

Guardion Health Sciences, Inc.'s (GHSI) CEO Dr.

GlobeNewsWire - 5 months ago

Newly-Appointed CFO Andrew Schmidt Brings Extensive and Wide-Ranging Public Company Experience

GlobeNewsWire - 6 months ago

The Only Computer Vision Testing Device to Combine Standardized Contrast Sensitivity Testing with a Full Suite of Clinical Vision Tests

GlobeNewsWire - 6 months ago

Patent Application Will Add to Guardion’s Intellectual Property Portfolio

GlobeNewsWire - 6 months ago

Fulfills Initial Order of Astramern from Astramune Sdn Bhd, a Subsidiary of Ho Wah Genting Berhad

GlobeNewsWire - 7 months ago

San Diego, California, June 15, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced today that its Board of Directors has appointed...

Forbes - 7 months ago

There are pockets of the stock market that look far too overvalued to ignore, and our deep learning algorithms paired with our Artificial Intelligence (“AI”) technology has identified the top ...

Other stocks mentioned: AVGR, KAR
Forbes - 7 months ago

The market is powering through its third consecutive day of massive gains. Whether the market is too optimistic has been on the minds of many, considering how unstable the economy has been thi...

Other stocks mentioned: BAND, COF, EYPT, HTBX
GlobeNewsWire - 8 months ago

-- First study to provide a head-to-head comparison of two commercially available supplements with regard to the changes in serum levels of carotenoids, visual function and macular pigment opt...

GlobeNewsWire - 9 months ago

– Presentation with live audio webcast on Wednesday, April 22 at 1:30 PM ET, immediately followed by an interactive Q&A session –

GlobeNewsWire - 9 months ago

- acuMMUNE now available for sale in the United States through online platforms -

GlobeNewsWire - 9 months ago

--Growing portfolio of synergistic assets and proprietary technologies

GlobeNewsWire - 9 months ago

- No immediate effect on the Company’s Nasdaq listing or the trading of its common stock -

GlobeNewsWire - 10 months ago

San Diego, California, March 06, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), an ocular health sciences company that develops, form...

Benzinga - 10 months ago

Shares of actively-traded penny stock Guardion Health Sciences Inc (NASDAQ: GHSI) are advancing after the company announced an agreement for developing an immuno-supportive formula.

GlobeNewsWire - 10 months ago

Guardion® has signed a Letter of Appointment with Ho Wah Genting Berhad (HWGB) to create a new formula, designed to enhance the immune system. The formula will be a unique and exclusive brand...

GlobeNewsWire - 11 months ago

  Formulation will be First Nutraceutical Compound to be Introduced Under Guardion’s Recently Acquired NutriGuard Business Line

GlobeNewsWire - 1 year ago

San Diego, California, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a leader in the field of ocular health technologies and ...

GlobeNewsWire - 1 year ago

San Diego, CA, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), today announced the closing of its previously announced underwri...

GlobeNewsWire - 1 year ago

San Diego, CA, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), announced the pricing of an underwritten public offering of 24,5...

GlobeNewsWire - 1 year ago

San Diego, California, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced that it has received approval from the USPTO fo...

GlobeNewsWire - 1 year ago

 Study Results Show 40 Times Higher Blood Concentration Levels of Mesozeaxanthin From Lumega-Z, Guardion’s Flagship Medical Food, as compared to Standard AREDS2 Over-The-Counter Gel Caps

GlobeNewsWire - 1 year ago

San Diego, California, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI), through its newly-formed wholly-owned subsidiary, Nutri...

GlobeNewsWire - 1 year ago

New Generation of Vision Testing Technology to be Introduced at Vision Expo West

Benzinga - 1 year ago

Guardion Health Sciences, Inc (NASDAQ: GHSI) shares are trading higher after the company announced it received a patent from the Patents Registry in Hong Kong for its proprietary medical devic...

About GHSI

Guardion Health Sciences, together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Medical Devices. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. The Medical Devices segment offers V... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
IPO Date
Apr 5, 2019
Stock Exchange
NASDAQ
Ticker Symbol
GHSI
Full Company Profile

Financial Performance

In 2019, GHSI's revenue was $902,937, a decrease of -4.16% compared to the previous year's $942,153. Losses were -$10.88 million, 40.1% more than in 2018.

Financial Statements